These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17577921)

  • 1. DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation.
    Hopfer O; Komor M; Koehler IS; Schulze M; Hoelzer D; Thiel E; Hofmann WK
    Exp Hematol; 2007 May; 35(5):712-23. PubMed ID: 17577921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.
    Hopfer O; Komor M; Koehler IS; Freitag C; Schulze M; Hoelzer D; Thiel E; Hofmann WK
    Leuk Res; 2009 Mar; 33(3):434-42. PubMed ID: 18829110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
    Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34(+) cells selected from patients with both low- and high-risk myelodysplastic syndrome.
    Gueller S; Komor M; Nowak D; Baldus CD; de Vos S; Hoelzer D; Ottmann OG; Hofmann WK
    Exp Hematol; 2010 Sep; 38(9):718-32, 732.e1-6. PubMed ID: 20621626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation analysis in myelodysplastic syndromes: diagnostic & prognostic implication.
    Solomon PR; Munirajan AK; Tsuchida N; Muthukumarasamy K; Rathinavel A; Selvam GS; Shanmugam G
    Indian J Med Res; 2008 Jan; 127(1):52-7. PubMed ID: 18316853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
    Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p15(ink4b) gene during megakaryocytic differentiation of normal and myelodysplastic hematopoietic progenitors.
    Teofili L; Martini M; Di Mario A; Rutella S; Urbano R; Luongo M; Leone G; Larocca LM
    Blood; 2001 Jul; 98(2):495-7. PubMed ID: 11435325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lower risk MDS patient at risk of rapid progression.
    Mittelman M; Oster HS; Hoffman M; Neumann D
    Leuk Res; 2010 Dec; 34(12):1551-5. PubMed ID: 20573398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins.
    Sloand EM; Pfannes L; Chen G; Shah S; Solomou EE; Barrett J; Young NS
    Blood; 2007 Mar; 109(6):2399-405. PubMed ID: 17090657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes.
    Aoki E; Uchida T; Ohashi H; Nagai H; Murase T; Ichikawa A; Yamao K; Hotta T; Kinoshita T; Saito H; Murate T
    Leukemia; 2000 Apr; 14(4):586-93. PubMed ID: 10764143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of methylation levels of multi-genes by real-time PCR in patients with myelodysplastic syndrome].
    Wang YC; DU X; Geng SX; Li YY; Weng JY; Lu ZS; Zhong LY; Deng CX; Lai PL; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):254-8. PubMed ID: 21569709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation profiling of archived non-small cell lung cancer: a promising prognostic system.
    Safar AM; Spencer H; Su X; Coffey M; Cooney CA; Ratnasinghe LD; Hutchins LF; Fan CY
    Clin Cancer Res; 2005 Jun; 11(12):4400-5. PubMed ID: 15958624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia.
    Hasegawa D; Manabe A; Kubota T; Kawasaki H; Hirose I; Ohtsuka Y; Tsuruta T; Ebihara Y; Goto Y; Zhao XY; Sakashita K; Koike K; Isomura M; Kojima S; Hoshika A; Tsuji K; Nakahata T
    Br J Haematol; 2005 Mar; 128(6):805-12. PubMed ID: 15755284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.
    Hopfer O; Nolte F; Mossner M; Komor M; Kmetsch A; Benslasfer O; Reissmann M; Nowak D; Hoelzer D; Thiel E; Hofmann WK
    Eur J Haematol; 2012 Feb; 88(2):144-53. PubMed ID: 21967505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation.
    Furukawa Y; Kikuchi J; Nakamura M; Iwase S; Yamada H; Matsuda M
    Br J Haematol; 2000 Sep; 110(3):663-73. PubMed ID: 10997979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
    Pellagatti A; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Verma A; Norbury CJ; Hellström-Lindberg E; Wainscoat JS; Boultwood J
    Leukemia; 2010 Apr; 24(4):756-64. PubMed ID: 20220779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes.
    del Rey M; O'Hagan K; Dellett M; Aibar S; Colyer HA; Alonso ME; Díez-Campelo M; Armstrong RN; Sharpe DJ; Gutiérrez NC; García JL; De Las Rivas J; Mills KI; Hernández-Rivas JM
    Leukemia; 2013 Mar; 27(3):610-8. PubMed ID: 22936014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrow.
    Van Dijk JP; Knops GH; Van De Locht LT; Menke AL; Jansen JH; Mensink EJ; Raymakers RA; De Witte T
    Br J Haematol; 2002 Sep; 118(4):1027-33. PubMed ID: 12199781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
    Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
    Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.